Cargando…
Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study
The use of tranexamic acid (TXA) in posterior lumbar interbody fusion (PLIF) surgery is believed to be beneficial for reducing intraoperative blood loss, postoperative drainage volume (PDV), and length of hospital stay (LOS). However, whether continued administration of intravenous TXA within 24 hou...
Autores principales: | Ji, Xianqun, Wang, Xiaochen, Shi, Liang, Tian, Fangtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659680/ https://www.ncbi.nlm.nih.gov/pubmed/37986288 http://dx.doi.org/10.1097/MD.0000000000035911 |
Ejemplares similares
-
Intravenous versus topical tranexamic acid in lumbar interbody fusion: A protocol of randomized controlled trial
por: Song, Fei, et al.
Publicado: (2020) -
Total and hidden blood loss between open posterior lumbar interbody fusion and transforaminal lumbar interbody fusion by Wiltse approach
por: Lei, Fei, et al.
Publicado: (2020) -
A retrospective controlled study protocol of transforaminal lumbar interbody fusion compared with posterior lumbar interbody fusion for spondylolisthesis
por: Yi, Ping, et al.
Publicado: (2020) -
Morphological analysis of interbody fusion following posterior lumbar interbody fusion with cages using computed tomography
por: Seo, Dong Kwang, et al.
Publicado: (2017) -
A retrospective controlled study of postoperative fever after posterior lumbar interbody fusion due to degenerative lumbar disease
por: Lee, Jung Jae, et al.
Publicado: (2022)